Pain-like behaviours in animals - How human are they?

Trends in Pharmacological Sciences

Volumn 25, Issue 6, 2004, Pages 299-305

  Blackburn Munro, Gordon ^a  

^a NEUROSEARCH A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; F 13640; FENTANYL; GABAPENTIN; GLUCOCORTICOID; KETAMINE; LAMOTRIGINE; METHOTREXATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEROTONIN 1A AGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; ANIMAL BEHAVIOR; ARTHRALGIA; ARTHRITIS; BIOCHEMISTRY; CANCER PAIN; CHRONIC PAIN; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; GENETIC MANIPULATION; HUMAN; INFLAMMATION; MYALGIA; NEUROPATHIC PAIN; NONHUMAN; PAIN; PAIN THRESHOLD; PERIPHERAL NEUROPATHY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STRESS; SYMPTOMATOLOGY; VALIDATION PROCESS; VISCERAL PAIN;

EID: 2542450995     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.04.008     Document Type: Article

References (64)

1. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature. 413:2001;203-210
2. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science. 288:2000;1765-1768
3. Hill R. NK1 (substance P) receptor antagonists-why are they not analgesic in humans? Trends Pharmacol. Sci. 21:2000;244-246
4. Villanueva L. Is there a gap between preclinical and clinical studies of analgesia? Trends Pharmacol. Sci. 21:2000;461-462
5. Tramer M.R., et al. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol. Scand. 42:1998;71-79
6. Flower R.J. The development of COX2 inhibitors. Nat. Rev. Drug Discov. 2:2003;179-191
7. Costello J.C., Halverson P.B. A new era in rheumatoid arthritis treatment. WMJ. 102:2003;29-33
8. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-24
9. Rowbotham M.C. Efficacy of opioids in neuropathic pain. Hansson P.T., et al. Neuropathic Pain: Pathophysiology and Treatment. 2001;203-214 IASP Press, Seattle
10. Backonja M. Anticonvulsants and antiarrhythmics in the treatment of neuropathic pain syndromes. Hansson P.T., et al. Neuropathic Pain: Pathophysiology and Treatment. 2001;185-201 IASP Press, Seattle
11. Carter G.T., Sullivan M.D. Antidepressants in pain management. Curr. Opin. Investig. Drugs. 3:2002;454-458
12. McQuay H.J., et al. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227
13. Sindrup S.H., Jensen T.S. Antidepressants in the treatment of neuropathic pain. Hansson P.T., et al. Neuropathic Pain: Pathophysiology and Treatment. 2001;169-183 IASP Press, Seattle
14. th World Congress on Pain (Dostrovsky, J.O. et al., eds), pp. 489-498, IASP Press.
15. Rainville P. Brain mechanisms of pain affect and pain modulation. Curr. Opin. Neurobiol. 12:2002;195-204
16. Chang C., Shyu B.C. A fMRI study of brain activations during non-noxious and noxious electrical stimulation of the rat sciatic nerve. Brain Res. 897:2001;71-81
17. Le Bars D., et al. Animal models of nociception. Pharmacol. Rev. 53:2001;597-652
18. Jensen T.S., et al. The clinical picture of neuropathic pain. Eur. J. Pharmacol. 429:2001;1-11
19. Dworkin R.H., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60:2003;1524-1534
20. Ochoa J.L., Yarnitsky D. Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann. Neurol. 33:1993;465-472
21. Field M.J., et al. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones? Pain. 83:1999;303-311
22. Field M.J., et al. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 80:1999;391-398
23. Decosterd I., et al. Progressive tactile hypersensitivity after a peripheral nerve crush: non-noxious mechanical stimulus-induced neuropathic pain. Pain. 100:2002;155-162
24. Staud R., et al. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain. 102:2003;87-95
25. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain. 1:1975;277-279
26. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 48:1997;332-338
27. + channel blockers in the formalin test. Eur. J. Pharmacol. 445:2002;231-238
28. Colpaert F.C. Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain. 28:1987;201-222
29. Calvino B., et al. Parallel clinical and behavioural studies of adjuvant induced arthritis in the rat: possible relationship with 'chronic pain'. Behav. Brain Res. 24:1987;11-29
30. Colpaert F.C., et al. Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats. Pain. 91:2001;33-45
31. Colpaert F.C., et al. Large-amplitude 5-HT(1A) receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology. 43:2002;945-958
32. Wang L.X., Wang Z.J. Animal and cellular models of neuropathic pain. Adv. Drug. Deliv. Rev. 55:2003;949-965
33. Choi Y., et al. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376
34. Wall P.D., et al. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain. 7:1979;103-111
35. Hansson P. Difficulties in stratifying neuropathic pain by mechanisms. Eur. J. Pain. 7:2003;353-357
36. Landis C.A., et al. Decreased slow-wave and paradoxical sleep in a rat chronic pain model. Sleep. 12:1989;167-177
37. Andersen M.L., Tufik S. Altered sleep and behavioral patterns of arthritic rats. Sleep Res. Online. 3:2000;161-167
38. Calvino B., et al. Ultrasonic vocalization (22-28 kHz) in a model of chronic pain, the arthritic rat: effects of analgesic drugs. NeuroReport. 7:1996;581-584
39. Jourdan D., et al. Analysis of ultrasonic vocalisation does not allow chronic pain to be evaluated in rats. Pain. 95:2002;165-173
40. Kontinen V.K., et al. Sleep and EEG patterns in the chronic constriction injury model of neuropathic pain. Physiol. Behav. 78:2003;241-246
41. Andersen M.L., Tufik S. Sleep patterns over 21-day period in rats with chronic constriction of sciatic nerve. Brain Res. 984:2003;84-92
42. Monassi C.R., et al. A subpopulation of rats show social and sleep-waking changes typical of chronic neuropathic pain following peripheral nerve injury. Eur. J. Neurosci. 17:2003;1907-1920
43. Wilson K.G., et al. Major depression and insomnia in chronic pain. Clin. J. Pain. 18:2002;77-83
44. Blackburn-Munro G., Blackburn-Munro R.E. Chronic pain, chronic stress and depression: coincidence or consequence? J. Neuroendocrinol. 13:2001;1009-1023
45. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11:2001;240-249
46. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science. 288:2000;1769-1772
47. Kontinen V.K., et al. Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain. 80:1999;341-346
48. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry. 7:2002;254-275
49. Chrousos G. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J. Allergy Clin. Immunol. 106:2000;S275-S291
50. Willner P., Mitchell P.J. The validity of animal models of predisposition to depression. Behav. Pharmacol. 13:2002;169-188
51. Blackburn-Munro G., Blackburn-Munro R.E. Pain in the brain: are hormones to blame? Trends Endocrinol. Metab. 14:2003;20-27
52. Harbuz M.S. Chronic inflammatory stress. Baillieres. Best Pract. Res. Clin. Endocrinol. Metab. 13:1999;555-565
53. Windle R.J., et al. Increased corticosterone pulse frequency during adjuvant-induced arthritis and its relationship to alterations in stress responsiveness. J. Neuroendocrinol. 13:2001;905-911
54. Merskey, H. and Bogduk. N. eds (1994) In Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms (2nd Edn), pp. 209-214, IASP Press, Seattle.
55. 't Hart, B.A. and Amor, S. (2003) The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system. Curr. Opin. Neurol. 16, 375-383.
56. Laird J.M., et al. A new model of visceral pain and referred hyperalgesia in the mouse. Pain. 92:2001;335-342
57. Boucher M., et al. Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. J. Urol. 164:2000;203-208
58. Sluka K.A., et al. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve. 24:2001;37-46
59. Radhakrishnan R., et al. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain. 104:2003;567-577
60. Kehl L.J., et al. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain. 85:2000;333-343
61. Vos B.P., et al. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J. Neurosci. 14:1994;2708-2723
62. Xu X.J., et al. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain. 48:1992;279-290
63. Kehl L.J., et al. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain. 103:2003;175-186
64. Shimoyama M., et al. A mouse model of neuropathic cancer pain. Pain. 99:2002;167-174